we are following all the developments in the house where lawmakers are on track to vote on a bill to raise the nation s debt limit. a key vote in this race to avoid default is just over two hours away and we re on it. u.s./china tensions soaring. a chinese fighter jet gets so close to a u.s. spy plane it causes turbulence. the pentagon is calling it an unnecessarily aggressive maneuver in international airspace. we ll have more on this close call ahead. and nasa tracking ufos. the space agency holding its first-ever public meeting on unidentified aerial phenomenon. the truth is out there. we re following these major developing stories and many more all coming in right here to cnn news central. heading to the house floor with no time to lose. soon the house will hold a critical vote on president biden and speaker kevin mccarthy s debt ceiling deal, with the nation barreling toward june 5th, the day the treasury department says it will no longer bow able to pay its bills.
the civil cases that are against us to go into the channels of bankruptcy, which is protocol anyway. but we want immunity from those cases and any future cases. well, at the time all the lawsuits between purdue pharma and the sacklers according to legal documents, $40 trillion is what it amounted to. and so that s when the negotiation started. as the appeal went on, the sacklers went up to $6 billion that they would put into the bankruptcy action. here s what s going to come from those $6 billion. first of all, they are going to go to victims compensation because all of those suits went into the channels of bankruptcy. it s going into the opioid crisis abatement programs for the local level, for the state level, all around the country. it will also go for overdose rescue medicines which are so important and purdue pharma, the
millions of americans addicted to a potentially deadly narcotic as part of its business plan. purdue and the sacklers dispute that. but in 2020, prosecutors said, quote, purdue admitted that it marketed and sold its dangerous opioid products to health care providers even though it had reason to believe those providers were diverting them to abusers, unquote. and, quote, the company lied to the drug enforcement administration about steps it had taken to prevent such diversion fraud lendly increasing the amount of its products it was permitted to sell. purdue also paid kickbacks to providers to encourage them to prescribe even more of its products, end quote. now a federal judge has approved a bankruptcy settlement between the sacklers, purdue pharma and a group of eight states and washington, d.c. under the deal the sacklers must pay out as much as $6 billion for opioid abatement programs, overdose rescue medicines to the states and to compensate victims. between 1999 and 2020 the u.s.